| CSK |
CSK: Tyrosine-protein kinase CSK |
TLK1 |
TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 |
0.738 |
Evidence |
|
| RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
CENTB2 |
CENTB2, KIAA0041: Centaurin-beta 2 |
0.738 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
E2F1 |
E2F1, RBBP3: Transcription factor E2F1 |
0.738 |
Evidence |
O
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
PRKDC |
PRKDC, HYRC, HYRC1: DNA-dependent protein kinase catalytic subunit |
0.738 |
Evidence |
|
| RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
BAZ2A |
BAZ2A, KIAA0314, TIP5: Bromodomain adjacent to zinc finger domain protein 2A |
0.738 |
Evidence |
|
| RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
CSTF2T |
CSTF2T, KIAA0689: Cleavage stimulation factor 64 kDa subunit, tau variant |
0.738 |
Evidence |
|
| RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
ZNF638 |
ZNF638, NP220, ZFML: Zinc finger protein 638 |
0.738 |
Evidence |
|
| RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
SFRS6 |
SFRS6, SRP55: Splicing factor, arginine/serine-rich 6 |
0.738 |
Evidence |
|
| RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
HNRPA0 |
HNRPA0: Heterogeneous nuclear ribonucleoprotein A0 |
0.738 |
Evidence |
|
| RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
0.738 |
Evidence |
|
| RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
0.738 |
Evidence |
|
| RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
EIF4G2 |
EIF4G2, DAP5, OK/SW-cl.75: Eukaryotic translation initiation factor 4 gamma 2 |
0.738 |
Evidence |
|
| RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
YBX1 |
YBX1, NSEP1, YB1: Nuclease sensitive element-binding protein 1 |
0.738 |
Evidence |
|
| TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
0.738 |
Evidence |
|
| CFHR2 |
CFHR2, CFHL2, FHR2, HFL3: Complement factor H-related protein 2 precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
0.738 |
Evidence |
|
| CFHR2 |
CFHR2, CFHL2, FHR2, HFL3: Complement factor H-related protein 2 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
0.738 |
Evidence |
|
| MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
E2F1 |
E2F1, RBBP3: Transcription factor E2F1 |
0.738 |
Evidence |
|
| ELF1 |
ELF1: ETS-related transcription factor Elf-1 |
BAZ2A |
BAZ2A, KIAA0314, TIP5: Bromodomain adjacent to zinc finger domain protein 2A |
0.738 |
Evidence |
|
| ELF1 |
ELF1: ETS-related transcription factor Elf-1 |
CCNL1 |
CCNL1, BM-001, UNQ530/PRO1073: Cyclin-L1 |
0.738 |
Evidence |
|
| ELF1 |
ELF1: ETS-related transcription factor Elf-1 |
RBL2 |
RBL2, RB2: Retinoblastoma-like protein 2 |
0.738 |
Evidence |
|
| S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
0.738 |
Evidence |
|
| SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
CFHR2 |
CFHR2, CFHL2, FHR2, HFL3: Complement factor H-related protein 2 precursor |
0.738 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
GMIP |
GMIP: GEM-interacting protein |
0.738 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
0.738 |
Evidence |
|
| JARID1A |
JARID1A, RBBP2, RBP2: Histone demethylase JARID1A |
GNB2L1 |
Lung cancer oncogene 7 |
0.738 |
Evidence |
|